Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bella Ungar

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
The Israel Medical Association Journal : IMAJ|December 26, 2021
Predictors of Immunogenicity to Infliximab among Patients with Inflammatory Bowel Disease: Does Ethnicity Matter?Ido Veisman, Doron Yablecovitch, Uri Kopylov, et al.
Inflammatory Bowel Diseases|August 30, 2020
Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn DiseaseAhmad Albshesh, Bella Ungar, Shomron Ben-Horin, et al.
Case Reports in Gastroenterology|August 11, 2022
Acute Chest Pain as an Infusion Reaction to VedolizumabAsaf Levartovsky, Miri Yavzori, Ella Fudim, et al.
Crohn'S & Colitis 360|February 13, 2023
Incidentally Diagnosed Asymptomatic Crohn's Disease: A Retrospective Cohort Study of Long-Term Clinical OutcomesAna Grinman, Bella Ungar, Adi Lahat, et al.
Annals of Gastroenterology|July 3, 2023
Outcome of inflammatory bowel disease patients with prior malignancyUria Shani, Eyal Klang, Simon Lassman, et al.
Journal of Crohn'S & Colitis|October 28, 2017
Vedolizumab in IBD-Lessons From Real-world Experience; A Systematic Review and Pooled AnalysisTal Engel, Bella Ungar, Diana E Yung, et al.
Journal of Clinical Medicine|August 30, 2020
Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease-Are We There Yet?Asaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, et al.
Case Reports in Gastroenterology|May 7, 2025
Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature ReviewNaama Lang, Yana Davidov, Tomer Hoffman, et al.
Journal of Clinical Medicine|March 10, 2022
Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract InfectionOffir Ukashi, Yiftach Barash, Eyal Klang, et al.
European Journal of Gastroenterology & Hepatology|November 8, 2024
Intestinal ultrasound accurately predicts future therapy failure in Crohn's disease patients in a biologics-induced remissionAhmad Albshesh, Alon Abend, Reuma Margalit Yehuda, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
The Israel Medical Association Journal : IMAJ|December 26, 2021
Predictors of Immunogenicity to Infliximab among Patients with Inflammatory Bowel Disease: Does Ethnicity Matter?Ido Veisman, Doron Yablecovitch, Uri Kopylov, et al.
Inflammatory Bowel Diseases|August 30, 2020
Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn DiseaseAhmad Albshesh, Bella Ungar, Shomron Ben-Horin, et al.
Case Reports in Gastroenterology|August 11, 2022
Acute Chest Pain as an Infusion Reaction to VedolizumabAsaf Levartovsky, Miri Yavzori, Ella Fudim, et al.
Crohn'S & Colitis 360|February 13, 2023
Incidentally Diagnosed Asymptomatic Crohn's Disease: A Retrospective Cohort Study of Long-Term Clinical OutcomesAna Grinman, Bella Ungar, Adi Lahat, et al.
Annals of Gastroenterology|July 3, 2023
Outcome of inflammatory bowel disease patients with prior malignancyUria Shani, Eyal Klang, Simon Lassman, et al.
Journal of Crohn'S & Colitis|October 28, 2017
Vedolizumab in IBD-Lessons From Real-world Experience; A Systematic Review and Pooled AnalysisTal Engel, Bella Ungar, Diana E Yung, et al.
Journal of Clinical Medicine|August 30, 2020
Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease-Are We There Yet?Asaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, et al.
Case Reports in Gastroenterology|May 7, 2025
Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature ReviewNaama Lang, Yana Davidov, Tomer Hoffman, et al.
Journal of Clinical Medicine|March 10, 2022
Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract InfectionOffir Ukashi, Yiftach Barash, Eyal Klang, et al.
European Journal of Gastroenterology & Hepatology|November 8, 2024
Intestinal ultrasound accurately predicts future therapy failure in Crohn's disease patients in a biologics-induced remissionAhmad Albshesh, Alon Abend, Reuma Margalit Yehuda, et al.
Pageof 9